Rovi Pharmaceuticals Laboratories

Clinical trials sponsored by Rovi Pharmaceuticals Laboratories, explained in plain language.

Now part of Laboratorios Farmaceuticos Rovi, S.A. ROVI BME

Pharmaceutical company focused on injectable drugs and heparin products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1 Not yet recruiting 1 Completed 3

Could a Four-Times-a-Year shot replace daily pills for breast cancer?

Disease control Recruiting now

This study tests whether a new quarterly injection of letrozole delivers the same amount of medicine into the body as the standard daily pill. It involves 120 postmenopausal women who have already completed at least 4-5 years of hormone therapy for early breast cancer. The goal i…

Phase 1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC

Rovi Pharmaceuticals Laboratories

Could a Four-Times-a-Year shot replace daily pills for breast cancer?